JP Morgan Chase’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Sell
785,834
-29,621
-4% -$117K ﹤0.01% 4060
2025
Q4
$3.32M Sell
815,455
-1,319,989
-62% -$5.91M ﹤0.01% 3681
2025
Q3
$7.58M Buy
2,135,444
+1,375,029
+181% +$4.97M ﹤0.01% 2969
2025
Q2
$2.08M Sell
760,415
-44,749
-6% -$92.3K ﹤0.01% 3891
2025
Q1
$1.35M Sell
805,164
-1,471
-0.2% -$4.11K ﹤0.01% 4145
2024
Q4
$1.31M Sell
806,635
-110,538
-12% -$330K ﹤0.01% 4439
2024
Q3
$3.82M Sell
917,173
-34,391
-4% -$181K ﹤0.01% 3424
2024
Q2
$5.2M Sell
951,564
-153,923
-14% -$1.23M ﹤0.01% 3006
2024
Q1
$11.1M Sell
1,105,487
-85,147
-7% -$638K ﹤0.01% 2386
2023
Q4
$4.86M Buy
1,190,634
+13,302
+1% +$49K ﹤0.01% 3112
2023
Q3
$4.56M Sell
1,177,332
-60,466
-5% -$325K ﹤0.01% 2912
2023
Q2
$7.38M Sell
1,237,798
-1,204,505
-49% -$6.94M ﹤0.01% 2554
2023
Q1
$7.99M Buy
2,442,303
+66,301
+3% +$265K ﹤0.01% 2478
2022
Q4
$9.38M Sell
2,376,002
-3,710
-0.2% -$18.1K ﹤0.01% 2320
2022
Q3
$14.3M Sell
2,379,712
-115,602
-5% -$834K ﹤0.01% 1858
2022
Q2
$16M Buy
2,495,314
+9,535
+0.4% +$60.7K ﹤0.01% 1792
2022
Q1
$20.5M Buy
2,485,779
+469,673
+23% +$3.8M ﹤0.01% 1751
2021
Q4
$31.2M Buy
2,016,106
+390,684
+24% +$7.53M ﹤0.01% 1476
2021
Q3
$36.6M Buy
1,625,422
+370,123
+29% +$7.77M ﹤0.01% 1346
2021
Q2
$24.7M Sell
1,255,299
-269,713
-18% -$6.11M ﹤0.01% 1664
2021
Q1
$51M Buy
+1,525,012
New +$49.7M 0.01% 1155

Other funds holding SANA